Neurogene Inc.
Neurogene Inc.（NGNE）股价预测与分析师目标价
华尔街共识、12 个月目标价、模型推演与 EPS/营收预期 — 来自分析师数据与历史行情。
ngne · 股价预测 · 6 位分析师（近3月）· FMP · 更新于 2026年6月8日
分析师评级与共识
基于过去 3 个月内 6 位华尔街分析师
Buy
6 位分析师
共识
评级分布
12 个月目标价
High
$70.00
Consensus
$69.50
+152.8% upside
Low
$69.00
Median: $69.5 · Last Close: $27.50
12 个月目标价预测
历史收盘价 + 分析师 12 个月目标价预测区间
Consensus Target
$69.50
152.8% upside
High Target
$70
154.6%
Low Target
$69
150.9%
Current Price
$27.50
as of today
Based on analyst price targets, the NGNE stock price prediction for the next 12 months ranges from $69 to $70. The consensus NGNE price forecast of $69.50 implies 152.8% upside from the current price of $27.50.
短期股价预测
Bull算法生成 · 每日更新
| Date | Predicted Price | Change |
|---|---|---|
| 2026-06-09 | $26.20 | ↓ 4.73% |
1-day model range: $26.01–$26.38. Peak: $26.38 (-4.73%).
长期股价预测
年度股价预测 · 2027 / 2028 / 2029 / 2030 / 2031
| Year | Avg Price | Change |
|---|---|---|
| 2027 | $14 | -47.7% |
| 2028 | $11 | -61.4% |
| 2029 | $9 | -67.0% |
| 2030 | $8 | -69.6% |
| 2031 | — | -70.9% |
基于技术分析的股价预测
14 项技术面信号（SMA×6 + EMA×6 + RSI + MACD）· EEAT 方法论透明
Market Sentiment
BULLISH
Based on 14 technical indicators
Refreshes daily from EOD close
Moving Averages · NGNE · Jun 8, 2026
最新分析师评级与调整
| Date | Brokerage | Action | Rating |
|---|---|---|---|
| 2026-04-06 | Canaccord Genuity | Maintains | Buy→Buy |
| 2026-01-13 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2025-11-13 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2025-10-31 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2025-10-09 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2025-06-12 | BMO Capital | Maintains | Outperform→Outperform |
| 2025-05-20 | BMO Capital | Maintains | Outperform→Outperform |
| 2025-05-16 | Baird | Downgrade ↓ | Outperform→Neutral |
| 2025-05-13 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2025-04-14 | BMO Capital | Maintains | Outperform→Outperform |
Wall Street analysts have recently issued updated ratings on Neurogene Inc. (NGNE) stock. Of the recent 29 rating actions, 0 were upgrades and 1 were downgrades. 6 analysts currently cover NGNE.
分析师推荐趋势
NGNE analyst recommendation trends show decreasing buy-side sentiment over the past 6 months. Buy rating actions changed from 2 to 1 per month.
财务预测：EPS 与营收一致预期
Revenue This Year
$0M
↓ 99.3% YoY
Revenue Next Year
$0M
↓ 100.0% YoY
EPS This Year
$-5.57
EPS Next Year
$-5.53
↓ 0.9% YoY
EPS ForecastReported vs Estimated
Analysts forecast NGNE EPS of $-5.57 for the current fiscal year, based on estimates from 7 analysts. The NGNE revenue forecast is $0M for the current year. These are analyst consensus estimates via FMP / S&P Global.
关于预测与目标价
NGNE 股价预测由两类独立数据源支撑：来自 6 位华尔街分析师（S&P Global / FMP）的共识评级，以及基于历史日终价计算的技术分析。NGNE 的共识目标价为 $69.50（+152.8% 上行空间），分析师共识为 Buy。
NGNE 的短期预测（明日）为 $26.20（-4.73%）。 NGNE 对 2027 年的股价预测均值为 $14。 NGNE 对 2030 年的预测区间为 $8–$9。
Neurogene Inc. 在 NASDAQ 上市，代码 NGNE。NGNE 在 2027 年的整体展望偏积极，在覆盖分析师中约 83% 对应 Buy 共识。
常见问题
NGNE 预测 · 8 个问题根据 6 位华尔街分析师，NGNE 的 12 个月平均目标价为 $69.50，最高 $70.00、最低 $69.00。若有图表，中位目标价可在上方查看。相对当前价 $27.50，隐含约 +152.8% 的上行空间。
· Analyst data: Financial Modeling Prep (FMP) · S&P Global Market Intelligence · Technical analysis: FMP /historical-price-eod/light · Updated: Hourly (analyst) · Daily (technical)
⚠ This information is provided for informational purposes only and does not constitute investment advice. Short-term and long-term price predictions are algorithmically generated and carry significant uncertainty. Past performance does not guarantee future results. Always conduct your own due diligence before making investment decisions.